Therapy-induced antitumor vaccination by targeting tumor necrosis factor-alpha to tumor vessels in combination with melphalan

Sassi, Francesca;
2007-01-01

2007
37
12
3381
3392
Antitumor immunity; CD4 priming; Melphalan; Th1/Th2 cells; TNF-α; Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; CD4-Positive T-Lymphocytes; Colonic Neoplasms; Combined Modality Therapy; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fibrosarcoma; Immunoconjugates; Immunoglobulin Fragments; Immunologic Memory; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Melphalan; Mice; Mice, Inbred BALB C; Mice, SCID; Neovascularization, Pathologic; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha; Vaccination; Immunology and Allergy; Immunology
Mortara, Lorenzo; Balza, Enrica; Sassi, Francesca; Castellani, Patrizia; Carnemolla, Barbara; De Lerma Barbaro, Andrea; Fossati, Sara; Tosi, Giovanna; Accolla, Roberto S.; Borsi, Laura
File in questo prodotto:
File Dimensione Formato  
Therapy.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 246.76 kB
Formato Adobe PDF
246.76 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1652568
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 39
social impact